INHIBITION OF TOLL‐LIKE RECEPTOR‐4, NUCLEAR FACTOR‐κB AND MITOGEN‐ACTIVATED PROTEIN KINASE BY LIGNOCAINE MAY INVOLVE VOLTAGE‐SENSITIVE SODIUM CHANNELS